Supplementary Tables – Real-world treatment of patients with palbociclib for HR+/HER2– advanced/metastatic breast cancer: the Europe IRIS study
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Tables_Real-world_treatment_of_patients_with_palbociclib_for_HR_HER2_advanced_metastatic_breast_cancer_the_Europe_IRIS_study/17091959
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table S1. Patient inclusion criteria
Supplementary Table S2. Therapeutic indications for IBRANCE
(palbociclib) in the EU
Supplementary Table S3. Patient demographics and clinical
characteristics for the nine individual EU countries
Supplementary Table S4. Palbociclib treatment patterns for the
nine individual EU countries
Supplementary Table S5. Response to palbociclib treatment for
the nine individual EU countries
Real-world treatment
of patients with palbociclib for HR+/HER2– advanced/metastatic breast cancer:
the Europe IRIS study
创建时间：
2021-11-29
